Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Goodhew, Erica B ^a   Morgan, Sheri Maria G ^b   Switzer, Andrew J ^c   Munoz, Beatriz ^d   Dize, Laura ^e   Gaydos, Charlotte ^e   Mkocha, Harran ^f   West, Sheila K ^d   Wiegand, Ryan E ^a   Lammie, Patrick J ^a   Martin, Diana L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c ST OLAF COLLEGE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f Kongwa Trachoma Project   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ANTIBODY RESPONSE; ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL (TOPIC); DRIED BLOOD SPOT TESTING; DRUG ADMINISTRATION; EYE EXAMINATION; HUMAN; LONGITUDINAL STUDY; MASS DRUG ADMINISTRATION; NONHUMAN; OCULAR SWAB; PRESCHOOL CHILD; SEROCONVERSION; SINGLE DRUG DOSE; SMEAR; TANZANIA; TRACHOMA; ANTIBODY PRODUCTION; BLOOD; EPIDEMIOLOGY; EYE; FEMALE; GENETICS; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MALE; METABOLISM; AGE; CONTROLLED STUDY; GROUPS BY AGE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PROGRAM EVALUATION; SENSITIVITY ANALYSIS; SEROPREVALENCE;

ANTI-BACTERIAL AGENTS; ANTIBODY FORMATION; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; CHLAMYDIA TRACHOMATIS; DNA, BACTERIAL; EYE; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; LONGITUDINAL STUDIES; MALE; TANZANIA; TRACHOMA;

EID: 84900321465     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-216     Document Type: Article

References (26)

1. Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 2009, 93:563-568. 10.1136/bjo.2008.148494, 19098034.
2. Goodhew EB, Priest JW, Moss DM, Zhong G, Munoz B, Mkocha H, Martin DL, West SK, Gaydos C, Lammie PJ. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl Trop Dis 2012, 6:e1873. 10.1371/journal.pntd.0001873, 3486877, 23133684.
3. Gass K, Beau de Rochars MV, Boakye D, Bradley M, Fischer PU, Gyapong J, Itoh M, Ituaso-Conway N, Joseph H, Kyelem D. A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. PLoS Negl Trop Dis 2012, 6:e1479. 10.1371/journal.pntd.0001479, 3260316, 22272369.
4. Moss DM, Priest JW, Boyd A, Weinkopff T, Kucerova Z, Beach MJ, Lammie PJ. Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis. Am J Trop Med Hyg 2011, 85:229-237. 10.4269/ajtmh.2011.11-0029, 3144818, 21813840.
5. Zhou XN, Xu J, Chen HG, Wang TP, Huang XB, Lin DD, Wang QZ, Tang L, Guo JG, Wu XH. Tools to support policy decisions related to treatment strategies and surveillance of Schistosomiasis japonica towards elimination. PLoS Negl Trop Dis 2011, 5:e1408. 10.1371/journal.pntd.0001408, 3243709, 22206024.
6. Dize L, West S, Quinn TC, Gaydos CA. Pooling ocular swab specimens from Tanzania for testing by Roche Amplicor and Aptima Combo 2 assays for the detection of Chlamydia trachomatis: accuracy and cost-savings. Diagn Microbiol Infect Dis 2013, 77:289-291. 10.1016/j.diagmicrobio.2013.08.005, 24079951.
7. Dize L, West S, Williams JA, Van Der Pol B, Quinn TC, Gaydos CA. Comparison of the Abbott m2000 RealTime CT assay and the Cepheid GeneXpert CT/NG assay to the Roche Amplicor CT assay for detection of Chlamydia trachomatis in ocular samples from Tanzania. J Clin Microbiol 2013, 51:1611-1613. 10.1128/JCM.00519-13, 3647953, 23486714.
8. Munoz B, Stare D, Mkocha H, Gaydos C, Quinn T, West SK. Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection?. Invest Ophthalmol Vis Sci 2011, 52:8806-8810. 10.1167/iovs.11-8074, 3230903, 22025578.
9. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987, 65:477-483. 2491032, 3500800.
10. Vickers AJ. The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study. BMC Med Res Methodol 2001, 1(6). doi:10.1186/1471-2288-1-6.
11. Schwarz G. Estimating the dimension for a model. Ann Stat 1978, 6:461-464.
12. Fay MP. Confidence intervals that match Fisher's exact or Blaker's exact tests. Biostatistics 2010, 11:373-374. 10.1093/biostatistics/kxp050, 2852239, 19948745.
13. Mariotti SP, Pararajasegaram R, Resnikoff S. Trachoma: looking forward to Global Elimination of Trachoma by 2020 (GET 2020). Am J Trop Med Hyg 2003, 69:33-35.
14. Bailey R, Duong T, Carpenter R, Whittle H, Mabey D. The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect 1999, 123:479-486. 10.1017/S0950268899003076, 2810784, 10694161.
15. Manz RA, Thiel A, Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997, 388:133-134. 10.1038/40540, 9217150.
16. Maruyama M, Lam KP, Rajewsky K. Memory B-cell persistence is independent of persisting immunizing antigen. Nature 2000, 407:636-642. 10.1038/35036600, 11034213.
17. Amanna IJ, Slifka MK, Crotty S. Immunity and immunological memory following smallpox vaccination. Immunol Rev 2006, 211:320-337. 10.1111/j.0105-2896.2006.00392.x, 16824139.
18. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003, 171:4969-4973. 10.4049/jimmunol.171.10.4969, 14607890.
19. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, Hanifin JM, Slifka MK. Duration of antiviral immunity after smallpox vaccination. Nat Med 2003, 9:1131-1137. 10.1038/nm917, 12925846.
20. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007, 357:1903-1915. 10.1056/NEJMoa066092, 17989383.
21. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008, 455:532-536. 10.1038/nature07231, 2848880, 18716625.
22. Herbrink P, van den Munckhof HA, Bumkens M, Lindeman J, van Dijk WC. Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay. Eur J Clin Microbiol Infect Dis 1988, 7:388-393. 10.1007/BF01962343, 3137040.
23. Kaldor J, Pritchard H, Serpell A, Metcalf W. Serum antibodies in Campylobacter enteritis. J Clin Microbiol 1983, 18:1-4. 270733, 6885981.
24. Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide LM, Fernandez-Merino C, Vidal C. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol 2008, 151:42-50. 2276914, 18005364.
25. McMillan SA, Douglas JP, Archbold GP, McCrum EE, Evans AE. Effect of low to moderate levels of smoking and alcohol consumption on serum immunoglobulin concentrations. J Clin Pathol 1997, 50:819-822. 10.1136/jcp.50.10.819, 500261, 9462262.
26. Macpherson AJ, Geuking MB, Slack E, Hapfelmeier S, McCoy KD. The habitat, double life, citizenship, and forgetfulness of IgA. Immunol Rev 2012, 245:132-146. 10.1111/j.1600-065X.2011.01072.x, 22168417.